[Atazanavir-induced nephrolithiasis]

MeSH terms

• Adenine / administration & dosage
• Adenine / adverse effects
• Adenine / analogs & derivatives
• Adenine / therapeutic use
• Adult
• Alkynes
• Antiretroviral Therapy, Highly Active
• Atazanavir Sulfate
• Benzoxazines / administration & dosage
• Benzoxazines / therapeutic use
• Cyclopropanes
• Dideoxynucleosides / administration & dosage
• Dideoxynucleosides / therapeutic use
• HIV Infections / complications
• HIV Infections / drug therapy*
• HIV Protease Inhibitors / administration & dosage
• HIV Protease Inhibitors / adverse effects*
• HIV Protease Inhibitors / therapeutic use
• Hepatitis B, Chronic / complications
• Hepatitis B, Chronic / drug therapy
• Hepatitis C, Chronic / complications
• Hepatitis D, Chronic / complications
• Humans
• Indinavir / administration & dosage
• Lamivudine / administration & dosage
• Lamivudine / therapeutic use
• Lopinavir
• Male
• Nephrolithiasis / chemically induced*
• Oligopeptides / administration & dosage
• Oligopeptides / adverse effects*
• Oligopeptides / therapeutic use
• Organophosphonates / administration & dosage
• Organophosphonates / adverse effects
• Organophosphonates / therapeutic use
• Pyridines / administration & dosage
• Pyridines / adverse effects*
• Pyridines / therapeutic use
• Pyrimidinones / administration & dosage
• Pyrimidinones / therapeutic use
• Reverse Transcriptase Inhibitors / administration & dosage
• Reverse Transcriptase Inhibitors / therapeutic use
• Ritonavir / administration & dosage
• Ritonavir / therapeutic use
• Stavudine / administration & dosage
• Stavudine / therapeutic use
• Tenofovir